AARTI DRUGS
|
AARTI DRUGS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹91 Cr | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr |
| Equity - Authorised | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr |
| Equity - Issued | ₹91 Cr | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr |
| Equity Paid Up | ₹91 Cr | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹1,278 Cr | ₹1,190 Cr | ₹1,100 Cr | ₹944 Cr | ₹820 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr |
| Profit & Loss Account Balance | ₹1,240 Cr | ₹1,155 Cr | ₹1,021 Cr | ₹879 Cr | ₹754 Cr |
| General Reserves | ₹16 Cr | ₹15 Cr | ₹61 Cr | ₹45 Cr | ₹48 Cr |
| Other Reserves | ₹15 Cr | ₹13 Cr | ₹12 Cr | ₹13 Cr | ₹12 Cr |
| Reserve excluding Revaluation Reserve | ₹1,278 Cr | ₹1,190 Cr | ₹1,100 Cr | ₹944 Cr | ₹820 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,369 Cr | ₹1,282 Cr | ₹1,192 Cr | ₹1,036 Cr | ₹913 Cr |
| Minority Interest | ₹0.34 Cr | ₹0.41 Cr | ₹0.23 Cr | ₹-0.06 Cr | ₹-0.02 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹280 Cr | ₹272 Cr | ₹196 Cr | ₹130 Cr | ₹139 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹280 Cr | ₹272 Cr | ₹392 Cr | ₹173 Cr | ₹139 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | ₹-196 Cr | ₹-44 Cr | - |
| Unsecured Loans | ₹3.57 Cr | ₹3.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹3.57 Cr | ₹3.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹78 Cr | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr |
| Deferred Tax Assets | ₹1.35 Cr | ₹1.02 Cr | - | - | - |
| Deferred Tax Liability | ₹80 Cr | ₹77 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr |
| Other Long Term Liabilities | ₹1.81 Cr | ₹1.08 Cr | ₹0.57 Cr | ₹2.05 Cr | ₹4.55 Cr |
| Long Term Trade Payables | - | - | - | ₹9.39 Cr | ₹6.34 Cr |
| Long Term Provisions | ₹4.33 Cr | ₹2.74 Cr | ₹3.04 Cr | ₹9.23 Cr | ₹22 Cr |
| Total Non-Current Liabilities | ₹368 Cr | ₹355 Cr | ₹279 Cr | ₹232 Cr | ₹257 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹416 Cr | ₹425 Cr | ₹480 Cr | ₹469 Cr | ₹330 Cr |
| Sundry Creditors | ₹416 Cr | ₹425 Cr | ₹480 Cr | ₹469 Cr | ₹330 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹145 Cr | ₹151 Cr | ₹100 Cr | ₹111 Cr | ₹105 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹34 Cr | ₹21 Cr | ₹11 Cr | - | - |
| Interest Accrued But Not Due | ₹2.43 Cr | ₹2.21 Cr | ₹1.71 Cr | ₹1.02 Cr | ₹0.80 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹108 Cr | ₹128 Cr | ₹87 Cr | ₹110 Cr | ₹105 Cr |
| Short Term Borrowings | ₹272 Cr | ₹215 Cr | ₹361 Cr | ₹356 Cr | ₹157 Cr |
| Secured ST Loans repayable on Demands | ₹216 Cr | ₹172 Cr | ₹311 Cr | ₹343 Cr | ₹96 Cr |
| Working Capital Loans- Sec | ₹216 Cr | ₹172 Cr | ₹311 Cr | ₹343 Cr | ₹96 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-160 Cr | ₹-130 Cr | ₹-262 Cr | ₹-329 Cr | ₹-34 Cr |
| Short Term Provisions | ₹4.29 Cr | ₹4.14 Cr | ₹8.60 Cr | ₹3.71 Cr | ₹2.80 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | ₹1.18 Cr | ₹4.23 Cr | - | - |
| Provision for post retirement benefits | - | - | - | - | ₹2.80 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹4.29 Cr | ₹2.95 Cr | ₹4.37 Cr | ₹3.71 Cr | - |
| Total Current Liabilities | ₹837 Cr | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr |
| Total Liabilities | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr |
| ASSETS | |||||
| Gross Block | ₹1,496 Cr | ₹1,388 Cr | ₹1,202 Cr | ₹1,169 Cr | ₹1,101 Cr |
| Less: Accumulated Depreciation | ₹630 Cr | ₹577 Cr | ₹526 Cr | ₹479 Cr | ₹436 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹866 Cr | ₹811 Cr | ₹676 Cr | ₹690 Cr | ₹665 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹274 Cr | ₹225 Cr | ₹187 Cr | ₹77 Cr | ₹19 Cr |
| Non Current Investments | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr |
| Long Term Investment | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr |
| Long Term Loans & Advances | ₹18 Cr | ₹20 Cr | ₹24 Cr | ₹28 Cr | ₹7.26 Cr |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹1,236 Cr | ₹1,112 Cr | ₹930 Cr | ₹815 Cr | ₹709 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹473 Cr | ₹486 Cr | ₹516 Cr | ₹526 Cr | ₹415 Cr |
| Raw Materials | ₹177 Cr | ₹183 Cr | ₹197 Cr | ₹222 Cr | ₹199 Cr |
| Work-in Progress | ₹117 Cr | ₹128 Cr | ₹173 Cr | ₹163 Cr | ₹112 Cr |
| Finished Goods | ₹128 Cr | ₹136 Cr | ₹117 Cr | ₹125 Cr | ₹89 Cr |
| Packing Materials | ₹5.03 Cr | ₹5.19 Cr | ₹4.78 Cr | ₹5.62 Cr | ₹3.71 Cr |
| Stores  and Spare | ₹15 Cr | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr |
| Other Inventory | ₹31 Cr | ₹13 Cr | ₹9.60 Cr | ₹0.08 Cr | - |
| Sundry Debtors | ₹751 Cr | ₹705 Cr | ₹865 Cr | ₹750 Cr | ₹555 Cr |
| Debtors more than Six months | ₹33 Cr | ₹43 Cr | ₹35 Cr | ₹27 Cr | ₹20 Cr |
| Debtors Others | ₹724 Cr | ₹664 Cr | ₹834 Cr | ₹727 Cr | ₹539 Cr |
| Cash and Bank | ₹7.56 Cr | ₹9.43 Cr | ₹8.96 Cr | ₹22 Cr | ₹9.78 Cr |
| Cash in hand | ₹0.19 Cr | ₹0.26 Cr | ₹0.28 Cr | ₹0.24 Cr | ₹0.30 Cr |
| Balances at Bank | ₹4.45 Cr | ₹7.12 Cr | ₹7.80 Cr | ₹22 Cr | ₹7.93 Cr |
| Other cash and bank balances | ₹2.92 Cr | ₹2.05 Cr | ₹0.88 Cr | ₹0.53 Cr | ₹1.55 Cr |
| Other Current Assets | ₹3.92 Cr | ₹3.23 Cr | ₹3.04 Cr | ₹0.70 Cr | ₹2.44 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹3.45 Cr | ₹2.78 Cr | ₹2.35 Cr | - | - |
| Other current_assets | ₹0.47 Cr | ₹0.45 Cr | ₹0.70 Cr | ₹0.70 Cr | ₹2.44 Cr |
| Short Term Loans and Advances | ₹103 Cr | ₹118 Cr | ₹99 Cr | ₹95 Cr | ₹74 Cr |
| Advances recoverable in cash or in kind | ₹24 Cr | ₹14 Cr | ₹14 Cr | ₹23 Cr | ₹20 Cr |
| Advance income tax and TDS | ₹10 Cr | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹69 Cr | ₹104 Cr | ₹85 Cr | ₹71 Cr | ₹54 Cr |
| Total Current Assets | ₹1,338 Cr | ₹1,321 Cr | ₹1,492 Cr | ₹1,393 Cr | ₹1,057 Cr |
| Net Current Assets (Including Current Investments) | ₹501 Cr | ₹525 Cr | ₹542 Cr | ₹453 Cr | ₹461 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr |
| Contingent Liabilities | ₹282 Cr | ₹249 Cr | ₹194 Cr | ₹185 Cr | ₹151 Cr |
| Total Debt | ₹612 Cr | ₹562 Cr | ₹607 Cr | ₹538 Cr | ₹344 Cr |
| Book Value | - | 139.40 | 128.77 | 111.92 | 98.01 |
| Adjusted Book Value | 149.99 | 139.40 | 128.77 | 111.92 | 98.01 |
Compare Balance Sheet of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,226.7 Cr | -10.8% | -7.5% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -10.8% |
-7.5% |
-4.3% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses